These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9191351)

  • 1. T lymphocyte activation and the cellular form of the prion protein, PrPc.
    Mabbott NA; Brown KL; Bruce ME
    Biochem Soc Trans; 1997 May; 25(2):307S. PubMed ID: 9191351
    [No Abstract]   [Full Text] [Related]  

  • 2. T-lymphocyte activation and the cellular form of the prion protein.
    Mabbott NA; Brown KL; Manson J; Bruce ME
    Immunology; 1997 Oct; 92(2):161-5. PubMed ID: 9415021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human FDC express PrPc in vivo and in vitro.
    Thielen C; Antoine N; Mélot F; Cesbron JY; Heinen E; Tsunoda R
    Dev Immunol; 2001; 8(3-4):259-66. PubMed ID: 11785675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of normal cellular prion protein (PrP(c)) on T lymphocytes and the effect of copper ion: Analysis by wild-type and prion protein gene-deficient mice.
    Kubosaki A; Nishimura-Nasu Y; Nishimura T; Yusa S; Sakudo A; Saeki K; Matsumoto Y; Itohara S; Onodera T
    Biochem Biophys Res Commun; 2003 Aug; 307(4):810-3. PubMed ID: 12878182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal cellular prion protein is preferentially expressed on subpopulations of murine hemopoietic cells.
    Liu T; Li R; Wong BS; Liu D; Pan T; Petersen RB; Gambetti P; Sy MS
    J Immunol; 2001 Mar; 166(6):3733-42. PubMed ID: 11238614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell mediated immune responses against human prion protein.
    Bainbridge J; Walker B
    Clin Exp Immunol; 2003 Sep; 133(3):310-7. PubMed ID: 12930355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for cellular prion protein in intrathymic T cell differentiation and migration?
    Terra-Granado E; Berbert LR; de Meis J; Nomizo R; Martins VR; Savino W; Silva-Barbosa SD
    Neuroimmunomodulation; 2007; 14(3-4):213-9. PubMed ID: 18073517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
    Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ
    J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.
    Sacquin A; Chaigneau T; Defaweux V; Adam M; Schneider B; Bruley Rosset M; Eloit M
    Brain Behav Immun; 2012 Aug; 26(6):919-30. PubMed ID: 22522067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and potential function of cellular prion protein in human lymphocytes.
    Li R; Liu D; Zanusso G; Liu T; Fayen JD; Huang JH; Petersen RB; Gambetti P; Sy MS
    Cell Immunol; 2001 Jan; 207(1):49-58. PubMed ID: 11161453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated PrPC expression predisposes to increased HSV-1 pathogenicity.
    Thackray AM; Bujdoso R
    Antivir Chem Chemother; 2006; 17(1):41-52. PubMed ID: 16542005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein expression and superoxide dismutase activity.
    Brown DR; Besinger A
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):423-9. PubMed ID: 9716501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cellular isoform of prion protein in T lymphocytes and bone marrow, analyzed by wild-type and prion protein gene-deficient mice.
    Kubosaki A; Yusa S; Nasu Y; Nishimura T; Nakamura Y; Saeki K; Matsumoto Y; Itohara S; Onodera T
    Biochem Biophys Res Commun; 2001 Mar; 282(1):103-7. PubMed ID: 11263978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of prion protein induces a primed state of type I interferon-responsive genes.
    Malachin G; Reiten MR; Salvesen Ø; Aanes H; Kamstra JH; Skovgaard K; Heegaard PMH; Ersdal C; Espenes A; Tranulis MA; Bakkebø MK
    PLoS One; 2017; 12(6):e0179881. PubMed ID: 28651013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction.
    Stuermer CA; Langhorst MF; Wiechers MF; Legler DF; Von Hanwehr SH; Guse AH; Plattner H
    FASEB J; 2004 Nov; 18(14):1731-3. PubMed ID: 15345693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory function in mice lacking or overexpressing the prion protein.
    Boudinot E; Tremblay P; Champagnat J; Foutz AS
    Neurosci Lett; 2002 Apr; 323(2):89-92. PubMed ID: 11950500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions: pathogenesis and reverse genetics.
    Aguzzi A; Klein MA; Montrasio F; Pekarik V; Brandner S; Furukawa H; Käser P; Röckl C; Glatzel M
    Ann N Y Acad Sci; 2000; 920():140-57. PubMed ID: 11193143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stable inhibition of human prion protein through a retrovirus-based RNAi system].
    Xu W; Wang D; Wang J; Yang H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1022-7. PubMed ID: 19835143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
    Daniels M; Cereghetti GM; Brown DR
    Eur J Biochem; 2001 Dec; 268(23):6155-64. PubMed ID: 11733010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.